IMUC
Price:
$0.1621
Market Cap:
$20.51M
EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum amino...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
IMUC
According to EOM Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 127.66%. This represents a change of 694.58% compared to the average of 16.07% of the last 4 quarters.
The mean historical ROE of EOM Pharmaceuticals Holdings, Inc. over the last ten years is -135.72%. The current 127.66% ROE has changed -194.06% with respect to the historical average. Over the past ten years (40 quarters), IMUC's ROE was at its highest in in the September 2017 quarter at 745.43%. The ROE was at its lowest in in the March 2017 quarter at -1216.77%.
Average
-135.72%
Median
-6.00%
Minimum
-1121.34%
Maximum
306.24%
Discovering the peaks and valleys of EOM Pharmaceuticals Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 980.94%
Maximum Annual ROE = 306.24%
Minimum Annual Increase = -114.79%
Minimum Annual ROE = -1121.34%
| Year | ROE | Change |
|---|---|---|
| 2025 | 80.30% | -73.78% |
| 2024 | 306.24% | 980.94% |
| 2023 | 28.33% | -55.17% |
| 2022 | 63.19% | -61.89% |
| 2021 | 165.81% | -114.79% |
| 2020 | -1121.34% | 181.51% |
| 2017 | -398.34% | 4.39% |
| 2016 | -381.58% | 541.25% |
| 2015 | -59.51% | 47.56% |
| 2014 | -40.33% | 22.01% |
The current ROE of EOM Pharmaceuticals Holdings, Inc. (IMUC) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
138.29%
5-year avg
128.78%
10-year avg
-135.72%
EOM Pharmaceuticals Holdings, Inc.’s ROE is less than Sirona Biochem Corp. (221.45%), less than Nymox Pharmaceutical Corporation (53.17%), less than Hemostemix Inc (92.37%), greater than HOOKIPA Pharma Inc. (-54.85%), greater than Algorae Pharmaceuticals Limited (-88.14%), greater than Devonian Health Group Inc. (-77.36%), less than PreveCeutical Medical Inc. (10.15%), greater than Propanc Biopharma, Inc. (-148.23%), greater than Oxford BioDynamics Plc (-451.74%), less than Quest PharmaTech Inc. (21.70%),
| Company | ROE | Market cap |
|---|---|---|
| 221.45% | $1.63M | |
| 53.17% | $1.89M | |
| 92.37% | $10.54M | |
| -54.85% | $14.40M | |
| -88.14% | $19.36M | |
| -77.36% | $16.34M | |
| 10.15% | $8.67M | |
| -148.23% | $1.39M | |
| -451.74% | $3.83M | |
| 21.70% | $3.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EOM Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like EOM Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is EOM Pharmaceuticals Holdings, Inc.'s ROE?
How is the ROE calculated for EOM Pharmaceuticals Holdings, Inc. (IMUC)?
What is the highest ROE for EOM Pharmaceuticals Holdings, Inc. (IMUC)?
What is the 3-year average ROE for EOM Pharmaceuticals Holdings, Inc. (IMUC)?
What is the 5-year average ROE for EOM Pharmaceuticals Holdings, Inc. (IMUC)?
How does the current ROE for EOM Pharmaceuticals Holdings, Inc. (IMUC) compare to its historical average?